Recently, the advanced lung cancer inflammation index (ALI), a new inflammatory marker that is calculated as BMI (kg/m2) × albumin (g/dL)/NLR, was initially found to be a useful prognostic index in lung cancer [12]. This evidence concerns the gene ALB and lung carcinoma.